Literature DB >> 14642954

Endometriosis from thelarche to midteens: pathogenesis and prognosis, prevention and pedagogy.

Ronald E Batt1, Mohamed F M Mitwally.   

Abstract

John Huffman, a founder of the subspecialty of pediatric and adolescent gynecology in North America, first related the diagnosis of endometriosis to thelarche. Subsequently, endometriosis was diagnosed in early puberty between thelarche and menarche. Based on solid evidence, we suggest that the theory of embryonic mullerian rests be added to currently accepted theories of pathogenesis of endometriosis. This article argues for recognition of embryonic mullerian rests as the pathogenesis of some cases of endometriosis not explained by accepted theories. Along with Huffman, we propose that thelarche be recognized as a developmental benchmark, after which endometriosis is included in the differential diagnosis of chronic pelvic pain. Thus, in an effort to refocus research and patient care to early adolescence, this review is limited to endometriosis occurring in young women from thelarche to their sixteenth birthday. Relating endometriosis to thelarche has fundamental implications for pathogenesis, early diagnosis, prognosis, treatment, education, and long-term care of adolescents.

Entities:  

Mesh:

Year:  2003        PMID: 14642954     DOI: 10.1016/j.jpag.2003.09.008

Source DB:  PubMed          Journal:  J Pediatr Adolesc Gynecol        ISSN: 1083-3188            Impact factor:   1.814


  12 in total

Review 1.  Imaging modalities for the non-invasive diagnosis of endometriosis.

Authors:  Vicki Nisenblat; Patrick M M Bossuyt; Cindy Farquhar; Neil Johnson; M Louise Hull
Journal:  Cochrane Database Syst Rev       Date:  2016-02-26

2.  Association of endometriosis with body size and figure.

Authors:  Mary L Hediger; Heather J Hartnett; Germaine M Buck Louis
Journal:  Fertil Steril       Date:  2005-11       Impact factor: 7.329

Review 3.  Blood biomarkers for the non-invasive diagnosis of endometriosis.

Authors:  Vicki Nisenblat; Patrick M M Bossuyt; Rabia Shaikh; Cindy Farquhar; Vanessa Jordan; Carola S Scheffers; Ben Willem J Mol; Neil Johnson; M Louise Hull
Journal:  Cochrane Database Syst Rev       Date:  2016-05-01

Review 4.  Endometrial biomarkers for the non-invasive diagnosis of endometriosis.

Authors:  Devashana Gupta; M Louise Hull; Ian Fraser; Laura Miller; Patrick M M Bossuyt; Neil Johnson; Vicki Nisenblat
Journal:  Cochrane Database Syst Rev       Date:  2016-04-20

5.  Herlyn-Werner-Wunderlich syndrome: uterus didelphys, blind hemivagina and ipsilateral renal agenesis. Sonographic and MR findings in 11 cases.

Authors:  Cinzia Orazi; M Chiara Lucchetti; Paolo M S Schingo; Paola Marchetti; Fabio Ferro
Journal:  Pediatr Radiol       Date:  2007-05-15

Review 6.  Urinary biomarkers for the non-invasive diagnosis of endometriosis.

Authors:  Emily Liu; Vicki Nisenblat; Cindy Farquhar; Ian Fraser; Patrick M M Bossuyt; Neil Johnson; M Louise Hull
Journal:  Cochrane Database Syst Rev       Date:  2015-12-23

Review 7.  Combination of the non-invasive tests for the diagnosis of endometriosis.

Authors:  Vicki Nisenblat; Lucy Prentice; Patrick M M Bossuyt; Cindy Farquhar; M Louise Hull; Neil Johnson
Journal:  Cochrane Database Syst Rev       Date:  2016-07-13

8.  Endometriosis in adolescence: a long-term follow-up fecundability assessment.

Authors:  Gary Ventolini; Gary M Horowitz; Ronald Long
Journal:  Reprod Biol Endocrinol       Date:  2005-04-21       Impact factor: 5.211

9.  Ectopic endometrium in human foetuses is a common event and sustains the theory of müllerianosis in the pathogenesis of endometriosis, a disease that predisposes to cancer.

Authors:  Pietro G Signorile; Feliciano Baldi; Rossana Bussani; Mariarosaria D'Armiento; Maria De Falco; Alfonso Baldi
Journal:  J Exp Clin Cancer Res       Date:  2009-04-09

10.  Endometriosis in adolescents is a hidden, progressive and severe disease that deserves attention, not just compassion.

Authors:  I Brosens; S Gordts; G Benagiano
Journal:  Hum Reprod       Date:  2013-06-05       Impact factor: 6.918

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.